Characterization of Impurities and Degradants Using Mass Spectrometry / Edition 1

Hardcover (Print)
Buy New
Buy New from
Used and New from Other Sellers
Used and New from Other Sellers
from $62.91
Usually ships in 1-2 business days
(Save 47%)
Other sellers (Hardcover)
  • All (7) from $62.91   
  • New (5) from $89.40   
  • Used (2) from $62.91   


The book highlights the current practices and future trends in structural characterization of impurities and degradants. It begins with an overview of mass spectrometry techniques as related to the analysis of impurities and degradants, followed by studies involving characterization of process related impurities (including potential genotoxic impurities), and excipient related impurities in formulated products. Both general practitioners in pharmaceutical research and specialists in analytical chemistry field will benefit from this book that will detail step-by-step approaches and new strategies to solve challenging problems related to pharmaceutical research.

Read More Show Less

Editorial Reviews

From the Publisher
"It will be valuable for scientists working in industrial, academic, and healthcare-related fields who use mass spectrometry to investigate impurities and degradants." (Doody's, 16 September 2011)
Doody's Review Service
Reviewer: Xiaochao Ma, PhD (University of Kansas Medical Center)
Description: This practical book covers the methodology and applications of mass spectrometry in the characterization of impurities and degradants. The authors are experts in this field from pharmaceutical companies and universities worldwide.
Purpose: The book presents comprehensive information about the use of mass spectrometry for the characterization of impurities and degradants.
Audience: It will be valuable for scientists working in industrial, academic, and healthcare-related fields who use mass spectrometry to investigate impurities and degradants.
Features: An introduction to mass spectrometry begins the book and is followed by its application in the characterization of impurities and degradants.
Assessment: This book is unique in its focus on the use of mass spectrometry in the characterization of impurities and degradants.
Read More Show Less

Product Details

Meet the Author

BIRENDRA N. PRAMANIK is a Distinguished Fellow at Merck Research Laboratories, where he directs spectroscopy programs covering mass spectrometry and NMR efforts. He was previously a distinguished fellow at Schering-Plough Research Institute. He received his PhD in organic chemistry under the late Professor Ajay K. Bose from Stevens Institute of Technology in 1977.

MIKE S. LEE is President of Milestone Development Services, a provider of consulting services specializing in pharmaceutical analysis and accelerated drug discovery and development strategies in Newtown, Pennsylvania. He previously directed program research at Bristol-Myers Squibb, Pharmaceutical Research Institute in New Brunswick, New Jersey.

GUODONG CHEN is Principal Scientist in Bioanalytical and Discovery Analytical Sciences at Bristol-Myers Squibb in Princeton, New Jersey. He heads a mass spectrometry group in support of drug discovery as well as development programs in small molecule pharmaceuticals and biologics. He received his PhD in analytical chemistry from Purdue University under the direction of Professor R. Graham Cooks.

Read More Show Less

Read an Excerpt
Read More Show Less

Table of Contents





1 Introduction to Mass Spectrometry (Scott A. Smith, Ruth Waddell Smith, Yu Xia, and Zheng Ouyang).

1.1 History.

1.2 Ionization Methods.

1.3 Mass Spectrometer Types.

1.4 Tandem Mass Spectrometry.

1.5 Separation Techniques Coupled to Mass Spectrometry.

1.6 Prospects for Mass Spectrometry.


2 LC Method Development and Strategies (Gang Xue and Yining Zhao).

2.1 Introduction.

2.2 Column, pH and Solvent Screening.

2.3 Gradient and Temperature Optimization.

2.4 Orthogonal Screening.

2.5 High-Efficiency Separation.

2.6 Conclusions.


3 Rapid Analysis of Drug-Related Substances using Desorption Electrospray Ionization and Direct Analysis in Real Time Ionization Mass Spectrometry (Hao Chen and Jiwen Li).

3.1 Introduction.

3.2 Ionization Apparatus, Mechanisms and General Performance.

3.3 Drug Analysis in Biological Matrices using DESI and DART.

3.4 High-Throughput Analysis.

3.5 Chemical Imaging and Profiling.

3.6 Future Perspectives.


4 Orbitrap High-Resolution Applications (Robert J. Strife).

4.1 Historical Anecdote.

4.2 General Description of Orbitrap Operating Principles.

4.3 The Orbitrap is a "Fourier Transform" Device.

4.4 Performing Experiments in Trapping Devices.

4.5 Determining Elemental Compositions of "Unknowns" Using an Orbitrap.

4.6 Orbitrap Figures of Merit in Mass Measurement.

4.7 HPLC Orbitrap MS: Accurate Mass Demonstration and Differentiation of Small Molecule Formulas Very Proximate in Mass/Charge Ratio Space.

4.8 Determination of Trace Contaminant Compositions by Simple Screening HPLC-MS and Infusion Orbitrap MS.

4.9 Determining Substructures: Orbitrap Tandem Mass Spectrometry (MSn).

4.10 Multianalyzer (Hybridized) System: The Linear Ion Trap/Orbitrap for MS/MS and Higher-Order MSn, n2.

4.11 Mass Mapping to Discover Impurities.

4.12 The Current Practice of Orbitrap Mass Spectrometry.

4.13 Conclusion.


5 Structural Characterization of Impurities and Degradation Products in Pharmaceuticals Using High-Resolution LC-MS and Online Hydrogen/Deuterium Exchange Mass Spectrometry (Guodong Chen and Birendra N. Pramanik).

5.1 Introduction.

5.2 Characterization of Impurities.

5.3 Characterization of Degradation Products.

5.4 Conclusions.


6 Isotope Patten Recognition on Molecular Formula Determination for Structural Identification of Impurities (Ming Gu).

6.1 Introduction.

6.2 Three Basic Approaches to Isotope Pattern Recognition.

6.3 The Importance of Lineshape Calibration.

6.4 Spectral Accuracy.

6.5 Formula Determination with Quadrupole MS.

6.6 Formula Determination with High-Resolution MS.

6.7 Conclusions and Future Directions.



7 Practical Application of Very High-Pressure Liquid Chromatography Across the Pharmaceutical Development-Manufacturing Continuum (Brent Kleintop and Qinggang Wang).

7.1 Introduction.

7.2 Theory and Benefits of VHPLC.

7.3 VHPLC Method Development.

7.4 Other Practical Considerations.

7.5 VHPLC Method Validation.

7.6 Summary.


8 Impurity Identification for Drug Substances (David W. Berberich, Tao Jiang, Joseph McClurg, Frank Moser, and R. Randy Wilhelm).

8.1 Introduction.

8.2 Case Studies.

8.3 Conclusions.


9 Impurity Identification in Process Chemistry by Mass Spectrometry (David Q. Liu, Mingjiang Sun, and Lianming Wu).

9.1 Introduction.

9.2 Experimentation.

9.3 Applications.

9.4 Concluding Remarks.



10 Structure Elucidation of Pharmaceutical Impurities and Degradants in Drug Formulation Development (Changkang Pan, Frances Liu, and Michael Motto).

10.1 Importance of Drug Degradation Studies in Drug Development.

10.2 Drug Degradation Studies in Formulation Development.

10.3 Complexity of Impurity Identification in Drug Development.

10.4 Strategy for Structure Elucidation of Unknowns.

10.5 Hyphenated Analytical Techniques Used in Drug Development.

10.6 Case Studies.



11 Investigation of Degradation Products and Extractables in Developing Topical OTC (Over the Counter) and NCE (New Chemical Entity) Consumer Healthcare Medication Products (Fa Zhang).

11.1 Introduction.

11.2 Oxidatively Induced Coupling of Miconazole Nitrate with Butylated Hydroxytoluene in a Topical Ointment.

11.3 Extractables from Rubber Closures of a Prefilled Semisolid Drug Applicator.

11.4 New Degradation Products and Pathways of Vitamin D and Its Analogs.

11.5 Reductive Degradation of a 1,2,4-Thiadiazolium Derivative.

11.6 Conclusions.


12. Characterization of Impurities and Degradants in Protein Therapeutics by Mass Spectrometry (Li Tao, Michael Ackerman, Wei Wu, Peiran Liu, and Reb Russell).

12.1 Introduction to Therapeutic Proteins.

12.2 Recent Advances in Mass Spectrometry.

12.3 Impurities.

12.4 Degradation Products.

12.5 Conclusions.


13 Identification and Quantification of Degradants and Impurities in Antibodies (David M. Hambly and Himanshu S. Gadgil).

13.1 Introduction to Antibodies and Protein Drugs.

13.2 Overview of Degradations and Impurities in Protein Drugs and Antibodies.

13.3 Methods to Identify and Quantitate Degradations and Impurities.

13.4 Conclusions.




Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Terms of Use.
  • - Barnes & reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)